Meth 2.0 and Opioid Use Disorder - A Collision of Epidemics

Tuesday, May 25, 2021, 11:00 AM - 12:30 PM, Webinar

The goal of the National Institute of Drug Abuse (NIDA) Clinical Trials Network webinar series is to help scholars and clinicians in the addiction field stay abreast of cutting edge science. In 2021, this will include the topics of combined use of opiates and stimulants, the role of stigma in the treatment of addiction and racial disparities in treatment. In this session, Dr. Larissa Mooney will discuss recent trends in co-occurring methamphetamine use and opioid use disorder (OUD), including overdose fatalities. Participants will also learn about the treatment approaches to address this rising comorbidity.

Registration for all practitioners - free

To register for this activity, please click HERE. 

AMA PRA Category 1 Credits™ (1.50 hours), Non-Physician Participation Credit (1.50 hours)

1. Recall at least two recent epidemiological trends in co-occurring methamphetamine use and opioid use disorder.
2. Identify at least three medical risks of co-occurring methamphetamine and opioid use.
3. Explain at least three evidence-based treatment approaches that can be utilized with patients who use both methamphetamine and opioids.

In support of improving patient care, this activity has been planned and implemented by Stanford Medicine and Northwest Addiction Technology Transfer Center. Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation

American Medical Association (AMA) 
Stanford Medicine designates this Live Activity for a maximum of 1.50 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require accommodations, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For activity related questions, please contact
     Name: Emily Manche
     Title: CME Compliance Coordinator
     Ph: 650-736-6195
     Email: [email protected]

For CME general questions, please contact 
     Ph: (650)-497-8554
     Email: [email protected]

Stanford Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education.

There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.